Peter Diamandis Says AI Goals Should Be More Benefits
Peter H. Diamandis stated on X that the goal of artificial intelligence should not be zero adverse outcomes, as the only way to achieve zero is to not try anything. He believes the goal should be to generate benefits that are several orders of magnitude greater than the harm.
Diamandis is the founder of XPRIZE and has long focused on exponential technologies and extending healthy lifespans. He has discussed AI safety, alignment incentives, and the decreasing costs of robots on the Moonshots podcast.
He recently pointed out that the cost of frontier models completing robotic sub-tasks has dropped from $2.36 in July to $0.38 in September, and he expects this trend to continue. He also suggested promoting alignment through insurance and prize mechanisms.
Diamandis has repeatedly emphasized the need to prioritize expanding AI applications in disease detection, scientific discovery, and resource acquisition, rather than solely focusing on potential risks. He positions AI as a tool to amplify human capabilities.
Related discussions involve how to balance risks and rewards in deployment. English reports and podcasts have recorded his views on alignment, incentives, and the scale of applications.
In terms of market mechanisms, laboratories attract capital and users through model capabilities and application scenarios. The beneficiaries are entities that deploy quickly and generate measurable benefits, while those under pressure are entities that delay applications due to excessive risk aversion.
Source: Public Information
ABAB AI Insight
Peter Diamandis founded XPRIZE and promoted several incentive prizes, consistently linking technological capabilities with specific goals. He has repeatedly discussed the application paths of AI in science, healthcare, and resource allocation in podcasts and public forums, while paying attention to the speed of cost reduction.
On the capital path, he guides funding towards verifiable outcomes through XPRIZE and related institutions. Resources are concentrated on establishing prizes and public discussions to influence the priorities of laboratories and investors, rather than directly controlling model training.
This is similar to other historical cases that guide technological safety through incentives and insurance mechanisms. Currently, we are in a phase of rapid improvement in model capabilities and expanding deployment scales, with alignment discussions shifting from abstract risks to actionable incentive designs.
Essentially, this is a technological substitution. The growth of AI capabilities changes the cost structure of scientific discovery and service delivery; when the goal shifts from zero adverse outcomes to net benefits, resource allocation moves from risk aversion to application expansion, altering the decision-making weight of laboratories and application parties.
ABAB News · Cognitive Laws
- Zero adverse outcomes equal zero attempts
- Orders of magnitude of benefits exceed absolute zero risk
- Incentives and insurance determine the speed of alignment